Holen Sie sich die Stockscreener-App
4.42
8.49%
-0.41
Schlusskurs vom Vortag:
$4.83
Offen:
$4.65
24-Stunden-Volumen:
320.56K
Relative Volume:
0.60
Marktkapitalisierung:
$114.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-25.46%
1M Leistung:
-29.62%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.39
$4.7627
1-Wochen-Bereich:
$4.20
$6.3075
52-Wochen-Spanne:
$4.20
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
6 CENTERPOINTE DR., LA PALMA
Vergleichen Sie LIMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
4.42 | 127.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Liminatus Pharma Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Liminatus Pharma Rings the Closing Bell - Nasdaq
Is it the right time to buy Liminatus Pharma Inc. stockOutstanding risk-reward balance - Jammu Links News
What institutional investors are buying Liminatus Pharma Inc. stockFree Stock Selection - Jammu Links News
Liminatus Pharma Inc. Stock Analysis and ForecastMaximize returns with disciplined trading - Jammu Links News
Why Liminatus Pharma Inc. stock attracts strong analyst attentionReal Profit Trade Plan Suggestions Shared Widely - beatles.ru
What makes Liminatus Pharma Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
Why is Liminatus Pharma Inc. stock attracting strong analyst attentionHigh-yield trading alerts - Jammu Links News
How many analysts rate Liminatus Pharma Inc. Equity Warrant as a “Buy”Invest confidently with data-backed picks - Jammu Links News
What are the technical indicators suggesting about Liminatus Pharma Inc.Free Trend-Following Techniques - Jammu Links News
How does Liminatus Pharma Inc. generate profit in a changing economyAccelerated financial growth - Jammu Links News
How volatile is Liminatus Pharma Inc. Equity Warrant stock compared to the marketAchieve consistent double-digit growth - Jammu Links News
What drives Liminatus Pharma Inc. Equity Warrant stock priceInvest confidently with professional advice - Jammu Links News
How does Liminatus Pharma Inc. Equity Warrant generate profit in a changing economyFree Investment Case Studies - Jammu Links News
What is the dividend policy of Liminatus Pharma Inc. Equity Warrant stockStay ahead with advanced stock screening tools - Jammu Links News
Is Liminatus Pharma Inc. Equity Warrant stock overvalued or undervaluedBreakthrough capital growth - Jammu Links News
What catalysts could drive Liminatus Pharma Inc. stock higher in 2025Superior risk-adjusted returns - Jammu Links News
What are Liminatus Pharma Inc. company’s key revenue driversCapitalize on momentum stocks early - Jammu Links News
What are the latest earnings results for Liminatus Pharma Inc. Equity WarrantFree Popular Stock Recommendations - Jammu Links News
What are Liminatus Pharma Inc. Equity Warrant company’s key revenue driversInvest confidently with actionable market data - Jammu Links News
How strong is Liminatus Pharma Inc. company’s balance sheetUnlock powerful insights from market experts - Jammu Links News
How does Liminatus Pharma Inc. compare to its industry peersAchieve breakthrough financial growth - Jammu Links News
What are analysts’ price targets for Liminatus Pharma Inc. Equity Warrant in the next 12 monthsDiscover hidden gems in the stock market - Jammu Links News
What analysts say about Liminatus Pharma Inc. Equity Warrant stockDiscover breakthrough stocks before the crowd - Jammu Links News
What makes Liminatus Pharma Inc. Equity Warrant stock price move sharplyInvest smarter with data-backed insights - Jammu Links News
What is the risk reward ratio of investing in Liminatus Pharma Inc. Equity Warrant stockWealth Building Review That Work - jammulinksnews.com
What is Liminatus Pharma Inc. company’s growth strategyExpert Picks Outlook For Beginners - jammulinksnews.com
What catalysts could drive Liminatus Pharma Inc. Equity Warrant stock higher in 2025Expert Picks Planner For Fast Growth - Jammu Links News
Is Liminatus Pharma Inc. forming a reversal patternAI Based High Gain Watchlist Scanner Shared - metal.it
When is Liminatus Pharma Inc. stock expected to show significant growthChart Pattern Planner For Beginners - Jammu Links News
Liminatus Pharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayQuick Gain Stock Watch With Indicators Reviewed - metal.it
😱🔥Liminatus Enters Crypto: $500 Million BNB Bomb Explodes!🤯💲 - Binance
Three Major Companies Announce $1.7 Billion in BNB Treasury Allocations, CZ Reacts - Coinspeaker
How does Liminatus Pharma Inc. Equity Warrant compare to its industry peersFree Stock Target Finder That Work - jammulinksnews.com
Custom Dashboard Highlights Liminatus Pharma Inc. Equity Warrant Price MomentumBuy Alerts With Low Risk Confirmation Noted - metal.it
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Es liegen keine Finanzdaten für Liminatus Pharma Inc (LIMN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):